|
1
|
Samson SL and Garber AJ: Metabolic
syndrome. Endocrinol Metab Clin North Am. 43:1–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giudice A, Crispo A, Massimiliano G,
D'Arena G, Tecce MF, Grimaldi M, Amore A, Esposito E and Montella
M: Metabolic syndrome, insulin resistance, circadian disruption,
antioxidants and pancreatic carcinoma: An overview. J
Gastrointestin Liver Dis. 23:73–77. 2014.PubMed/NCBI
|
|
3
|
Hoffman EL, VonWald T and Hansen K: The
metabolic syndrome. S D Med. 9:24–28. 2015.
|
|
4
|
Festa A, D'Agostino R Jr, Howard G,
Mykkänen L, Tracy RP and Haffner SM: Chronic subclinical
inflammation as part of the insulin resistance syndrome: The
insulin resistance atherosclerosis study (IRAS). Circulation.
102:42–47. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suerbaum S and Michetti P: Helicobacter
pylori infection. N Engl J Med. 347:1175–1186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McColl KE: Clinical practice. Helicobacter
pylori infection. N Engl J Med. 362:1597–1604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qadri Q, Rasool R, Gulzar GM, Naqash S and
Shah ZA: H. pylori infection, inflammation and gastric cancer. J
Gastrointest Cancer. 45:126–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Atherton JC: The pathogenesis of
Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev
Pathol. 1:63–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee YC, Chen TH, Chiu HM, Shun CT, Chiang
H, Liu TY, Wu MS and Lin JT: The benefit of mass eradication of
Helicobacter pylori infection: A community-based study of gastric
cancer prevention. Gut. 62:676–682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malfertheiner P, Megraud F, O'Morain CA,
Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton
J, Graham DY, et al: Management of Helicobacter pylori
infection-the Maastricht V/Florence Consensus Report. Gut. 66:6–30.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oshima T, Ozono R, Yano Y, Oishi Y,
Teragawa H, Higashi Y, Yoshizumi M and Kambe M: Association of
Helicobacter pylori infection with systemic inflammation and
endothelial dysfunction in healthy male subjects. J Am Coll
Cardiol. 45:1219–1222. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Franceschi F, Annalisa T, Teresa DR,
Giovanna D, Ianiro G, Franco S, Viviana G, Valentina T, Riccardo LL
and Antonio G: Role of Helicobacter pylori infection on nutrition
and metabolism. World J Gastroenterol. 20:12809–12817. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kyburz A and Muller A: Helicobacter pylori
and extragastric diseases. Curr Top Microbiol Immunol. 400:325–347.
2017.PubMed/NCBI
|
|
14
|
Goni E and Franceschi F: Helicobacter
pylori and extragastric diseases. Helicobacter. 21 (Suppl
1):S45–S48. 2016. View Article : Google Scholar
|
|
15
|
Albaker WI: Helicobacter pylori infection
and its relationship to metabolic syndrome: Is it a myth or fact?
Saudi J Gastroenterol. 17:165–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen LW, Chien CY, Yang KJ, Kuo SF, Chen
CH and Chien RN: Helicobacter pylori infection increases insulin
resistance and metabolic syndrome in residents younger than 50
years old: A community-based study. PLoS One. 10:e01286712015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen TP, Hung HF, Chen MK, Lai HH, Hsu WF,
Huang KC and Yang KC: Helicobacter pylori infection is positively
associated with metabolic syndrome in taiwanese adults: A
cross-sectional study. Helicobacter. 20:184–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Işıktaş Sayılar E, Çelik B and Dumlu Ş:
Relationship between Helicobacter pylori infection and metabolic
syndrome. Turk J Gastroenterol. 26:468–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koklu H, Koklu S and Cinar H: Helicobacter
pylori and metabolic syndrome. Turk J Gastroenterol. 27:2012016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vafaeimanesh J, Bagherzadeh M, Mirzaei A,
Parham M, Norouzinia M and Vafaee R: Effect of Helicobacter pylori
on metabolic syndrome parameters in diabetic patients.
Gastroenterol Hepatol Bed Bench. 9 (Suppl 1):S36–S41.
2016.PubMed/NCBI
|
|
21
|
Upala S, Jaruvongvanich V, Riangwiwat T,
Jaruvongvanich S and Sanguankeo A: Association between Helicobacter
pylori infection and metabolic syndrome: A systematic review and
meta-analysis. J Dig Dis. 17:433–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Polyzos SA and Kountouras J: Novel
advances in the association between helicobacter pylori infection,
metabolic syndrome, and related morbidity. Helicobacter.
20:405–409. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kayar Y, Pamukçu Ö, Eroğlu H, Kalkan Erol
K, Ilhan A and Kocaman O: Relationship between Helicobacter pylori
infections in diabetic patients and inflammations, metabolic
syndrome, and complications. Int J Chronic Dis.
2015:2901282015.PubMed/NCBI
|
|
24
|
Lu LJ, Hao NB, Liu JJ, Li X and Wang RL:
Correlation between Helicobacter pylori infection and metabolic
abnormality in general population: A cross-sectional study.
Gastroenterol Res Pract. 2018:74108012018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang W and Xuan C: Influence of
Helicobacter pylori infection on metabolic syndrome in old chinese
people. Gastroenterol Res Pract. 2016:69512642016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ando T, Ishikawa T, Takagi T, Imamoto E,
Kishimoto E, Okajima A, Uchiyama K, Handa O, Yagi N, Kokura S, et
al: Impact of Helicobacter pylori eradication on circulating
adiponectin in humans. Helicobacter. 18:158–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Luis DA, Garcia Avello A, Lasuncion MA,
Aller R, Martin de Argila C, Boixeda de Miquel D and de la Calle H:
Improvement in lipid and haemostasis patterns after Helicobacter
pylori infection eradication in type 1 diabetic patients. Clin
Nutr. 18:227–231. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gen R, Demir M and Ataseven H: Effect of
Helicobacter pylori eradication on insulin resistance, serum lipids
and low-grade inflammation. South Med J. 103:190–196. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Devaraj S, Rosenson RS and Jialal I:
Metabolic syndrome: An appraisal of the pro-inflammatory and
procoagulant status. Endocrinol Metab Clin North Am. 33:431–453.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gillum RF: Infection with Helicobacter
pylori, coronary heart disease, cardiovascular risk factors, and
systemic inflammation: The third national health and nutrition
examination survey. J Natl Med Assoc. 96:1470–1476. 2004.PubMed/NCBI
|
|
31
|
Naja F, Nasreddine L, Hwalla N, Moghames
P, Shoaib H, Fatfat M, Sibai A and Gali-Muhtasib H: Association of
H. pylori infection with insulin resistance and metabolic syndrome
among lebanese adults. Helicobacter. 17:444–451. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tamura T, Morita E, Kawai S, Sasakabe T,
Sugimoto Y, Fukuda N, Suma S, Nakagawa H, Okada R, Hishida A, et
al: No association between Helicobacter pylori infection and
diabetes mellitus among a general Japanese population: A
cross-sectional study. Springerplus. 4:6022015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miernyk KM, Bruden DL, Bruce MG, McMahon
BJ, Hennessy TW, Peters HV, Hurlburt DA, Sacco F and Parkinson AJ:
Dynamics of Helicobacter pylori-specific immunoglobulin G for 2
years after successful eradication of Helicobacter pylori infection
in an American Indian and Alaska native population. Clin Vaccine
Immunol. 14:85–86. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ferwana M, Abdulmajeed I, Alhajiahmed A,
Madani W, Firwana B, Hasan R, Altayar O, Limburg PJ, Murad MH and
Knawy B: Accuracy of urea breath test in Helicobacter pylori
infection: Meta-analysis. World J Gastroenterol. 21:1305–1314.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alberti KG, Zimmet P and Shaw J; IDF
Epidemiology Task Force Consensus Group, : The metabolic syndrome-a
new worldwide definition. Lancet. 366:1059–1062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gayoso-Diz P, Otero-González A,
Rodriguez-Alvarez MX, Gude F, García F, De Francisco A and Quintela
AG: Insulin resistance (HOMA-IR) cut-off values and the metabolic
syndrome in a general adult population: Effect of gender and age:
EPIRCE cross-sectional study. BMC Endocr Disord. 13:472013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shin DW, Kwon HT, Kang JM, Park JH, Choi
HC, Park MS, Park MS, Park SM, Son KY and Cho B: Association
between metabolic syndrome and Helicobacter pylori infection
diagnosed by histologic status and serological status. J Clin
Gastroenterol. 46:840–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Refaeli R, Chodick G, Haj S, Goren S,
Shalev V and Muhsen K: Relationships of H. pylori infection and its
related gastroduodenal morbidity with metabolic syndrome: A large
cross-sectional study. Sci Rep. 8:40882018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Figueroa-Vega N, Moreno-Frías C and
Malacara JM: Alterations in adhesion molecules, pro-inflammatory
cytokines and cell-derived microparticles contribute to
intima-media thickness and symptoms in postmenopausal women. PLoS
One. 10:e01209902015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Taleb-Belkadi O, Chaib H, Zemour L, Fatah
A, Chafi B and Mekki K: Lipid profile, inflammation, and oxidative
status in peri- and postmenopausal women. Gynecol Endocrinol.
32:982–985. 2016. View Article : Google Scholar : PubMed/NCBI
|
